In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,440 | -30,437 | -30,007 | -28,521 | -14,653 |
| Depreciation Amortization | 2,501 | 2,655 | 2,501 | 1,103 | 788 |
| Accounts payable and accrued liabilities | -80 | -535 | -981 | 1,510 | -319 |
| Other Working Capital | 1,038 | -1,412 | -204 | -170 | -1,839 |
| Other Operating Activity | 3,269 | 5,580 | 5,351 | 1,957 | 2,514 |
| Operating Cash Flow | $-12,712 | $-24,149 | $-23,340 | $-24,121 | $-13,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -187 | -600 | -3,705 | -309 |
| Investing Cash Flow | $N/A | $-187 | $-600 | $-3,705 | $-309 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -693 | -794 | -798 | -615 | -535 |
| Common Stock Issued | 29,331 | 14,978 | 27,842 | 9,603 | 36,357 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,867 |
| Financing Cash Flow | $28,638 | $14,184 | $27,044 | $8,988 | $32,955 |
| Beginning Cash Position | 11,386 | 21,538 | 18,434 | 37,272 | 18,135 |
| End Cash Position | 27,312 | 11,386 | 21,538 | 18,434 | 37,272 |
| Net Cash Flow | $15,926 | $-10,152 | $3,104 | $-18,838 | $19,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,712 | -24,149 | -23,340 | -24,121 | -13,509 |
| Capital Expenditure | N/A | -187 | -600 | -3,705 | -309 |
| Free Cash Flow | -12,712 | -24,336 | -23,940 | -27,826 | -13,818 |